All Stories

  1. Opportunities for improving animal welfare in rodent models of epilepsy and seizures
  2. A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy
  3. International Veterinary Epilepsy Task Force’s current understanding of idiopathic epilepsy of genetic or suspected genetic origin in purebred dogs
  4. International Veterinary Epilepsy Task Force consensus reports on epilepsy definition, classification and terminology, affected dog breeds, diagnosis, treatment, outcome measures of therapeutic trials, neuroimaging and neuropathology in companion animals
  5. International veterinary epilepsy task force consensus proposal: diagnostic approach to epilepsy in dogs
  6. International veterinary epilepsy task force consensus report on epilepsy definition, classification and terminology in companion animals
  7. International Veterinary Epilepsy Task Force recommendations for a veterinary epilepsy-specific MRI protocol
  8. International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
  9. International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy
  10. International veterinary epilepsy task force recommendations for systematic sampling and processing of brains from epileptic dogs and cats
  11. INTER- AND INTRAOBSERVER AGREEMENT FOR DIAGNOSING PRESUMPTIVE ISCHEMIC MYELOPATHY AND ACUTE NONCOMPRESSIVE NUCLEUS PULPOSUS EXTRUSION IN DOGS USING MAGNETIC RESONANCE IMAGING
  12. Clinical Forum: how to manage canine epilepsy successfully?
  13. Thoracic and Lumbar Vertebral Bone Mineral Density Changes in a Natural Occurring Dog Model of Diffuse Idiopathic Skeletal Hyperostosis
  14. Assessment into the usage of levetiracetam in a canine epilepsy clinic
  15. Inter-observer agreement of canine and feline paroxysmal event semiology and classification by veterinary neurology specialists and non-specialists
  16. Development of learning objectives for neurology in a veterinary curriculum: part I: undergraduates
  17. Development of learning objectives for neurology in a veterinary curriculum: Part II: Postgraduates
  18. Canine AED efficacy
  19. Treatment in canine epilepsy – a systematic review
  20. Clinical Risk Factors Associated with Anti-Epileptic Drug Responsiveness in Canine Epilepsy
  21. PREVALENCE AND CHARACTERIZATION OF SMALL TYMPANIC BONE SPICULES AND DRUMSTICK-LIKE HYPEROSTOTIC TYMPANIC BONE SPICULES IN THE MIDDLE EAR CAVITY OF DOGS
  22. Clinical signs and outcome of dogs treated medically for degenerative lumbosacral stenosis: 98 cases (2004–2012)
  23. Novel Approach to Temporal Lobectomy for Removal of a Cavernous Hemangioma in a Dog
  24. The influence of sex hormones on seizures in dogs and humans
  25. Biochemical and Cytological Examination of Cerebrospinal Fluid
  26. Future approaches to tackling neuropathic pain in dogs
  27. A retrospective study of the prevalence of the canine degenerative myelopathy associated superoxide dismutase 1 mutation (SOD1:c.118G > A) in a referral population of German Shepherd dogs from the UK
  28. Idiopathic head tremor in english bulldogs
  29. Venous sinus volume in the caudal cranial fossa in Cavalier King Charles spaniels with syringomyelia
  30. How Long and Low Can You Go? Effect of Conformation on the Risk of Thoracolumbar Intervertebral Disc Extrusion in Domestic Dogs
  31. COMPARISON OF CLOSURE TIMES FOR CRANIAL BASE SYNCHONDROSES IN MESATICEPHALIC, BRACHYCEPHALIC, AND CAVALIER KING CHARLES SPANIEL DOGS
  32. Public perception of epilepsy in dogs is more favorable than in humans
  33. What Is Your Neurologic Diagnosis?
  34. IMAGING DIAGNOSIS-MALIGNANT PERIPHERAL NERVE SHEATH TUMOR PRESENTING AS AN INTRA-AXIAL BRAIN MASS IN A YOUNG DOG
  35. Questionnaire-based behaviour analysis of Cavalier King Charles spaniels with neuropathic pain due to Chiari-like malformation and syringomyelia
  36. Surgical Treatment of an Intracranial Epidermoid Cyst in a Dog
  37. Increase in Cerebellar Volume in Cavalier King Charles Spaniels with Chiari-like Malformation and Its Role in the Development of Syringomyelia
  38. Changes over time in craniocerebral morphology and syringomyelia in cavalier King Charles spaniels with Chiari-like malformation
  39. Intervertebral disk width in dogs with and without clinical signs of disk associated cervical spondylomyelopathy
  40. Volume reduction of the jugular foramina in Cavalier King Charles Spaniels with syringomyelia
  41. Distribution of syringomyelia along the entire spinal cord in clinically affected Cavalier King Charles Spaniels
  42. Neuromuscular Disorders in the Cat: Clinical Approach to Weakness
  43. MRI FEATURES OF CNS LYMPHOMA IN DOGS AND CATS
  44. Brain Abscess in Seven Cats Due to a Bite Wound: MRI Findings, Surgical Management and Outcome
  45. IMAGING DIAGNOSIS-SPINAL CORD HEMANGIOMA IN TWO DOGS
  46. Behavioral changes in dogs associated with the development of idiopathic epilepsy
  47. Treatment of Hydrocephalus with Ventriculoperitoneal Shunting in Twelve Dogs
  48. IMAGING THE CRANIAL NERVES
  49. ORIGINAL RESEARCH: Significance of surface epithelial cells in canine cerebrospinal fluid and relationship to central nervous system disease
  50. Foreign body induced neuritis masquerading as a canine brachial plexus nerve sheath tumour
  51. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs
  52. Prophylactic treatment with levetiracetam after status epilepticus: Lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats
  53. Expression of the multidrug transporter MRP2 in the blood–brain barrier after pilocarpine-induced seizures in rats
  54. Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABAA receptor ligand binding in a model of temporal lobe epilepsy
  55. Striking Differences in Individual Anticonvulsant Response to Phenobarbital in Rats with Spontaneous Seizures after Status Epilepticus
  56. Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats
  57. Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats
  58. Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats